Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS)

CUSIP: 09075A108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
66,970,133
Total 13F shares
33,976,343
Share change
+2,351,709
Total reported value
$231,717,964
Price per share
$6.82
Number of holders
93
Value change
+$12,640,844
Number of buys
60
Number of sells
40

Quarterly Holders Quick Answers

What is CUSIP 09075A108?
CUSIP 09075A108 identifies BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BVS - Bioventus Inc. - Class A Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Essex Woodlands Management, Inc.
13F
Company
18%
12,096,702
$170,563,000 31 Mar 2022
13F
Juniper Investment Company, LLC
13F
Company
4.1%
2,761,657
$38,939,000 31 Mar 2022
13F
ROYCE & ASSOCIATES LP
13F
Company
2.9%
1,943,183
$27,399,000 31 Mar 2022
13F
BlackRock Finance, Inc.
13F
Company
2.7%
1,783,087
$25,143,000 31 Mar 2022
13F
SV Health Investors, LLC
13F
Company
2.2%
1,488,596
$20,989,000 31 Mar 2022
13F
NUANCE INVESTMENTS, LLC
13F
Company
2%
1,352,101
$19,065,000 31 Mar 2022
13F
Redmile Group, LLC
13F
Company
1.9%
1,296,739
$18,284,000 31 Mar 2022
13F
VANGUARD GROUP INC
13F
Company
1.7%
1,121,064
$15,807,000 31 Mar 2022
13F
First Light Asset Management, LLC
13F
Company
1.3%
901,525
$12,712,000 31 Mar 2022
13F
Tamarack Advisers, LP
13F
Company
1.2%
825,001
$11,633,000 31 Mar 2022
13F
Stavros G. Vizirgianakis
3/4/5
Director
mixed-class rows
2,798,536
mixed-class rows
$11,582,581 16 Jun 2022
WASATCH ADVISORS LP
13F
Company
1.1%
706,908
$9,967,000 31 Mar 2022
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
0.83%
555,910
$7,838,000 31 Mar 2022
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
0.8%
536,850
$7,570,000 31 Mar 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.67%
449,380
$6,336,000 31 Mar 2022
13F
STATE STREET CORP
13F
Company
0.64%
428,784
$6,046,000 31 Mar 2022
13F
JPMORGAN CHASE & CO
13F
Company
0.54%
362,635
$5,113,000 31 Mar 2022
13F
NORTHERN TRUST CORP
13F
Company
0.37%
246,547
$3,476,000 31 Mar 2022
13F
SALEM INVESTMENT COUNSELORS INC
13F
Company
0.35%
235,145
$3,316,000 31 Mar 2022
13F
STEPHENS INC /AR/
13F
Company
0.35%
234,346
$3,304,000 31 Mar 2022
13F
First Eagle Investment Management, LLC
13F
Company
0.27%
180,722
$2,548,000 31 Mar 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.25%
170,169
$2,400,000 31 Mar 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.25%
165,933
$2,340,000 31 Mar 2022
13F
Bank of New York Mellon Corp
13F
Company
0.23%
153,707
$2,166,000 31 Mar 2022
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.17%
115,772
$1,632,000 31 Mar 2022
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.15%
102,125
$1,439,000 31 Mar 2022
13F
RAYMOND JAMES & ASSOCIATES
13F
Company
0.14%
91,397
$1,289,000 31 Mar 2022
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.13%
87,948
$1,240,000 31 Mar 2022
13F
HRT FINANCIAL LP
13F
Company
0.12%
83,619
$1,179,000 31 Mar 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.1%
67,586
$928,000 31 Mar 2022
13F
DEAN INVESTMENT ASSOCIATES, LLC
13F
Company
0.09%
62,573
$882,000 31 Mar 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.09%
62,122
$876,000 31 Mar 2022
13F
AFFINITY INVESTMENT ADVISORS, LLC
13F
Company
0.09%
58,450
$824,000 31 Mar 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.07%
46,573
$657,000 31 Mar 2022
13F
Granite Point Capital Management, L.P.
13F
Company
0.06%
43,339
$611,000 31 Mar 2022
13F
Dean Capital Management
13F
Company
0.06%
42,595
$601,000 31 Mar 2022
13F
Raymond James Financial Services Advisors, Inc.
13F
Company
0.06%
39,210
$553,000 31 Mar 2022
13F
DAVENPORT & Co LLC
13F
Company
0.05%
36,679
$517,000 31 Mar 2022
13F
FIRST HAWAIIAN BANK
13F
Company
0.05%
33,980
$479,000 31 Mar 2022
13F
FIRST TRUST ADVISORS LP
13F
Company
0.05%
31,895
$450,000 31 Mar 2022
13F
MORGAN STANLEY
13F
Company
0.05%
31,381
$443,000 31 Mar 2022
13F
IndexIQ Advisors LLC
13F
Company
0.04%
29,598
$417,000 31 Mar 2022
13F
RHUMBLINE ADVISERS
13F
Company
0.04%
28,200
$398,000 31 Mar 2022
13F
Mariner, LLC
13F
Company
0.04%
28,017
$395,000 31 Mar 2022
13F
STRS OHIO
13F
Company
0.04%
26,500
$373,000 31 Mar 2022
13F
John Nosenzo
3/4/5
Fmr. Chief Commercial Officer
class O/S missing
87,148
$360,688 01 Apr 2022
PRUDENTIAL FINANCIAL INC
13F
Company
0.04%
25,398
$358,000 31 Mar 2022
13F
GABELLI FUNDS LLC
13F
Company
0.04%
25,200
$355,000 31 Mar 2022
13F
JANE STREET GROUP, LLC
13F
Company
0.04%
25,152
$355,000 31 Mar 2022
13F
Ergoteles LLC
13F
Company
0.03%
23,200
$327,000 31 Mar 2022
13F

Institutional Holders of Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) as of Q2 2022

As of 30 Jun 2022, Bioventus Inc. - Class A Common Stock, $0.001 par value per share (BVS) was held by 93 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,976,343 shares. The largest 10 holders included Essex Woodlands Management, Inc., Juniper Investment Company, LLC, BlackRock Inc., ROYCE & ASSOCIATES LP, SV Health Investors, LLC, First Light Asset Management, LLC, Redmile Group, LLC, BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, and Tamarack Advisers, LP. This page lists 93 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders
100
Q2 2022 holders
93
Holder diff
-7
Investor Q1 2022 Shares Q2 2022 Shares Share Diff Share Chg % Q1 2022 Value $ Q2 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .